FIGURE 1
FROM:
Monocyte chemoattractant protein-1 regulation of blood−brain barrier permeability
Svetlana M Stamatovic, Parvin Shakui, Richard F Keep, Bethany B Moore, Steven L Kunkel, Nico Van Rooijen and Anuska V Andjelkovic
BACK TO ARTICLEFigure 1.

Intracerebral administration of monocyte chemoattractant protein (MCP-1) induces fluorescein isothiocyanate (FITC)-albumin leakage in the brain. FITC-albumin leakage into mouse brain was assayed at 6,12, 24 and 48 h after an acute dose of recombinant murine MCP-1 (25
g) or after long-term infusion for 3 (5
g/h) or 7 days (2.5
g/h). Mice treated with saline were used as control. (A) Quantitative analysis of MCP-1 induced FITC-albumin leakage in the brain after intracerebral MCP-1 treatment. Values are Means
s.d., #P<0.001 compared with control, (n=5 animals per group). (B) Representative images of FITC-albumin leakage in the brain after intracerebral MCP-1 treatment. Scale bar=1000
m.
